Press releases

Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global Medical Response (GMR) and Cardinal Health who will each...

Cardinal Health (NYSE: CAH) today provided a fiscal year 2022 financial update for the Medical segment. The company now expects additional inflationary impacts and lower volumes resulting...

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2022 on February 3 prior to the opening of trading on the New York Stock Exchange. The company...

CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)-- AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that the deadline for...

Melbourne (Australia) and Indianapolis, IN (U.S.A.) – 20 December 2021. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a global biopharmaceutical company focused on the...

Cardinal Health today announced its business, WaveMark™ Supply Management and Workflow Solutions, will now be available for implementation in clinical labs across the U.S. "WaveMark is among the...

Kannapolis, NC—Nov. 16, 2021 – Cardinal Health (NYSE: CAH) and Zipline, the global leader in instant logistics, today announced a collaboration to offer on-demand autonomous aircraft delivery...

Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. First quarter GAAP operating earnings...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on January 15, 2022 to shareholders of...

Cardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE) study as part...

Paoli, PA — Cardinal Health Specialty Solutions and Gastrologix, the only gastroenterology (GI)-specific group purchasing organization (GPO) in the United States, working in conjunction with the...

Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including Diabetic Kidney Disease (DKD), today...

Cardinal Health (NYSE: CAH) announced today its Strategic Stock Solution now serves nearly 40 hospitals and health systems nationwide, just one year after its launch. In October last year, the...

CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an...

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2022 on November 9 prior to the opening of trading on the New York Stock Exchange. The company will...

DUBLIN, Ohio—Cardinal Health (NYSE: CAH) today launched the Reimbursement Solution—a comprehensive approach designed to help hospitals and health systems minimize their number of claim...

AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that, under the previously announced proposed settlement agreement and process designed to...

DUBLIN, OHIO and FLEURUS, BELGIUM – AUGUST 26, 2021 – Cardinal Health (NYSE: CAH) and IRE ELiT (the radiopharmaceutical subsidiary of IRE Group) are working to expand patient access to novel...

DUBLIN, OHIO – August 20, 2021 — Cardinal Health (NYSE: CAH) issued a voluntary Medical Device correction notice on June 16, 2021 for Argyle™ UVC Insertion Tray containing Safety Scalpel...

DUBLIN, OHIO – August 19, 2021 — On August 4, 2021, Cardinal Health (NYSE: CAH) initiated a nationwide recall of approximately 267 million MonojectTM Flush Prefilled Saline Syringes (0.9%...

Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 2.616% notes due June 2022 that are outstanding as...

Cardinal Health (NYSE: CAH) announced today that it has extended its agreements with CVS Health to distribute pharmaceuticals to retail pharmacies and distribution centers through June 30, 2027....

Cardinal Health (NYSE: CAH) today reported that fourth-quarter fiscal 2021 revenue increased 16% to $42.6 billion. This increase includes the favorable prior year comparison from reduced...

Chronicled and Cardinal Health today announced a partnership to leverage a new blockchain-powered solution on the MediLedger Network to streamline operations across the pharmaceutical supply chain...